CA Stock MarketDetailed Quotes

XRTX XORTX Therapeutics Inc

Watchlist
  • 2.100
  • +0.050+2.44%
15min DelayMarket Closed Nov 7 16:00 ET
6.77MMarket Cap-4150P/E (TTM)

XORTX Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
57.41%-736.54K
47.54%-1.3M
26.56%-6.58M
64.08%-1.3M
-10.66%-1.07M
7.95%-1.73M
0.74%-2.49M
-86.70%-8.96M
-14.81%-3.61M
-6,422.15%-967.56K
Net income from continuing operations
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.57%-1.2M
Operating gains losses
-35,770.39%-1.64M
12,163.50%1.73M
-11.96%-3.66M
-312.04%-3.64M
100.27%2.16K
99.67%-4.58K
92.42%-14.36K
-25.17%-3.26M
90.55%-882.99K
-112.76%-792.44K
Depreciation and amortization
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
557.56%22.06K
Remuneration paid in stock
43.10%44.03K
34.35%53.13K
-75.21%120.98K
-57.43%28.82K
13.40%21.85K
-90.76%30.77K
-41.90%39.55K
23.09%487.94K
-42.44%67.68K
-54.31%19.27K
Other non cashItems
--0
--224.49K
----
----
----
----
----
----
----
----
Change In working capital
790.17%659.18K
56.14%-326.87K
-169.94%-1.03M
-70.44%-412.21K
-77.35%222.17K
-122.89%-95.51K
-334.66%-745.19K
236.03%1.47M
68.58%-241.84K
334.93%980.72K
-Change in receivables
34.44%8.08K
-34.20%29.83K
151.20%21.04K
140.47%7.53K
-129.02%-37.83K
108.73%6.01K
153.96%45.33K
-39.87%-41.1K
36.67%-18.61K
--130.36K
-Change in prepaid assets
448.89%431.74K
-442.78%-402.07K
-77.09%142.65K
52.92%-148.04K
-53.00%94.74K
-83.12%78.66K
-56.49%117.3K
178.34%622.6K
56.87%-314.46K
1,531.91%201.6K
-Change in payables and accrued expense
161.53%110.85K
105.00%45.37K
-233.87%-1.19M
-397.83%-271.7K
-74.53%165.25K
-988.26%-180.18K
-787.81%-907.82K
444.07%892.27K
908.34%91.23K
170.81%648.77K
Cash from discontinued investing activities
Operating cash flow
57.41%-736.54K
47.54%-1.3M
26.56%-6.58M
64.08%-1.3M
-10.66%-1.07M
7.95%-1.73M
0.74%-2.49M
-86.70%-8.96M
-14.81%-3.61M
-6,422.15%-967.56K
Investing cash flow
Cash flow from continuing investing activities
4.76%-9.08K
86.71%-2.62K
-1.45%-46.36K
41.75%-9.8K
-56.50%-7.3K
55.81%-9.54K
-647.39%-19.73K
-43.68%-45.7K
-20.58%-16.82K
50.51%-4.66K
Net PPE purchase and sale
--0
--0
78.11%-4.31K
99.98%-1
--0
88.89%-1.64K
---2.67K
---19.7K
---5.42K
--458
Net intangibles purchas and sale
-14.97%-9.08K
84.62%-2.62K
-61.71%-42.05K
14.02%-9.79K
-42.50%-7.3K
-15.31%-7.9K
-546.14%-17.06K
18.24%-26.01K
18.32%-11.39K
45.65%-5.12K
Cash from discontinued investing activities
Investing cash flow
4.76%-9.08K
86.71%-2.62K
-1.45%-46.36K
41.75%-9.8K
-56.50%-7.3K
55.81%-9.54K
-647.39%-19.73K
-43.68%-45.7K
-20.58%-16.82K
50.51%-4.66K
Financing cash flow
Cash flow from continuing financing activities
12.66%-8.86K
7,851.59%1.7M
-107.67%-361.04K
-106.03%-312.25K
96.38%-16.67K
-63.72%-10.14K
-21.98K
-75.69%4.71M
-62.80%5.18M
-123.59%-460.78K
Net issuance payments of debt
45.83%-8.86K
0.73%-15.95K
-223.81%-66.09K
-755.66%-17K
-36.34%-16.67K
-163.98%-16.35K
---16.06K
---20.41K
---1.99K
---12.23K
Net common stock issuance
--0
--2M
--0
----
----
--0
--0
-72.34%5M
----
----
Proceeds from stock option exercised by employees
--0
5,497.97%16.57K
362.50%296
--0
--0
--0
--296
-100.00%64
-99.99%64
--0
Net other financing activities
--0
-4,692.38%-297.61K
-9.53%-295.25K
----
----
----
---6.21K
61.41%-269.56K
248.81%179K
----
Cash from discontinued financing activities
Financing cash flow
12.66%-8.86K
7,851.59%1.7M
-107.67%-361.04K
-106.03%-312.25K
96.38%-16.67K
-63.72%-10.14K
---21.98K
-75.69%4.71M
-62.80%5.18M
-123.59%-460.78K
Net cash flow
Beginning cash position
-51.50%3.84M
-66.96%3.45M
-29.83%10.43M
-42.86%5.07M
-40.81%6.16M
-36.28%7.91M
-29.83%10.43M
10,954.34%14.87M
126.44%8.87M
150.81%10.41M
Current changes in cash
56.86%-754.48K
115.71%397.09K
-62.59%-6.99M
-204.79%-1.62M
23.61%-1.09M
8.26%-1.75M
-0.82%-2.53M
-129.57%-4.3M
-85.63%1.55M
-522.12%-1.43M
Effect of exchange rate changes
-154.37%-2.49K
-903.19%-9.32K
102.97%4.04K
-109.02%-1.45K
99.78%-246
105.02%4.58K
-97.60%1.16K
-169.51%-136.15K
-91.78%16.1K
---109.44K
End cash Position
-50.06%3.08M
-51.50%3.84M
-66.96%3.45M
-66.96%3.45M
-42.86%5.07M
-40.81%6.16M
-36.28%7.91M
-29.83%10.43M
-29.83%10.43M
126.44%8.87M
Free cash from
57.12%-745.62K
47.84%-1.31M
26.41%-6.63M
63.98%-1.31M
-10.88%-1.08M
8.49%-1.74M
0.06%-2.5M
-86.42%-9.01M
-14.83%-3.63M
-3,907.55%-972.22K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 57.41%-736.54K47.54%-1.3M26.56%-6.58M64.08%-1.3M-10.66%-1.07M7.95%-1.73M0.74%-2.49M-86.70%-8.96M-14.81%-3.61M-6,422.15%-967.56K
Net income from continuing operations 110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.57%-1.2M
Operating gains losses -35,770.39%-1.64M12,163.50%1.73M-11.96%-3.66M-312.04%-3.64M100.27%2.16K99.67%-4.58K92.42%-14.36K-25.17%-3.26M90.55%-882.99K-112.76%-792.44K
Depreciation and amortization 3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K557.56%22.06K
Remuneration paid in stock 43.10%44.03K34.35%53.13K-75.21%120.98K-57.43%28.82K13.40%21.85K-90.76%30.77K-41.90%39.55K23.09%487.94K-42.44%67.68K-54.31%19.27K
Other non cashItems --0--224.49K--------------------------------
Change In working capital 790.17%659.18K56.14%-326.87K-169.94%-1.03M-70.44%-412.21K-77.35%222.17K-122.89%-95.51K-334.66%-745.19K236.03%1.47M68.58%-241.84K334.93%980.72K
-Change in receivables 34.44%8.08K-34.20%29.83K151.20%21.04K140.47%7.53K-129.02%-37.83K108.73%6.01K153.96%45.33K-39.87%-41.1K36.67%-18.61K--130.36K
-Change in prepaid assets 448.89%431.74K-442.78%-402.07K-77.09%142.65K52.92%-148.04K-53.00%94.74K-83.12%78.66K-56.49%117.3K178.34%622.6K56.87%-314.46K1,531.91%201.6K
-Change in payables and accrued expense 161.53%110.85K105.00%45.37K-233.87%-1.19M-397.83%-271.7K-74.53%165.25K-988.26%-180.18K-787.81%-907.82K444.07%892.27K908.34%91.23K170.81%648.77K
Cash from discontinued investing activities
Operating cash flow 57.41%-736.54K47.54%-1.3M26.56%-6.58M64.08%-1.3M-10.66%-1.07M7.95%-1.73M0.74%-2.49M-86.70%-8.96M-14.81%-3.61M-6,422.15%-967.56K
Investing cash flow
Cash flow from continuing investing activities 4.76%-9.08K86.71%-2.62K-1.45%-46.36K41.75%-9.8K-56.50%-7.3K55.81%-9.54K-647.39%-19.73K-43.68%-45.7K-20.58%-16.82K50.51%-4.66K
Net PPE purchase and sale --0--078.11%-4.31K99.98%-1--088.89%-1.64K---2.67K---19.7K---5.42K--458
Net intangibles purchas and sale -14.97%-9.08K84.62%-2.62K-61.71%-42.05K14.02%-9.79K-42.50%-7.3K-15.31%-7.9K-546.14%-17.06K18.24%-26.01K18.32%-11.39K45.65%-5.12K
Cash from discontinued investing activities
Investing cash flow 4.76%-9.08K86.71%-2.62K-1.45%-46.36K41.75%-9.8K-56.50%-7.3K55.81%-9.54K-647.39%-19.73K-43.68%-45.7K-20.58%-16.82K50.51%-4.66K
Financing cash flow
Cash flow from continuing financing activities 12.66%-8.86K7,851.59%1.7M-107.67%-361.04K-106.03%-312.25K96.38%-16.67K-63.72%-10.14K-21.98K-75.69%4.71M-62.80%5.18M-123.59%-460.78K
Net issuance payments of debt 45.83%-8.86K0.73%-15.95K-223.81%-66.09K-755.66%-17K-36.34%-16.67K-163.98%-16.35K---16.06K---20.41K---1.99K---12.23K
Net common stock issuance --0--2M--0----------0--0-72.34%5M--------
Proceeds from stock option exercised by employees --05,497.97%16.57K362.50%296--0--0--0--296-100.00%64-99.99%64--0
Net other financing activities --0-4,692.38%-297.61K-9.53%-295.25K---------------6.21K61.41%-269.56K248.81%179K----
Cash from discontinued financing activities
Financing cash flow 12.66%-8.86K7,851.59%1.7M-107.67%-361.04K-106.03%-312.25K96.38%-16.67K-63.72%-10.14K---21.98K-75.69%4.71M-62.80%5.18M-123.59%-460.78K
Net cash flow
Beginning cash position -51.50%3.84M-66.96%3.45M-29.83%10.43M-42.86%5.07M-40.81%6.16M-36.28%7.91M-29.83%10.43M10,954.34%14.87M126.44%8.87M150.81%10.41M
Current changes in cash 56.86%-754.48K115.71%397.09K-62.59%-6.99M-204.79%-1.62M23.61%-1.09M8.26%-1.75M-0.82%-2.53M-129.57%-4.3M-85.63%1.55M-522.12%-1.43M
Effect of exchange rate changes -154.37%-2.49K-903.19%-9.32K102.97%4.04K-109.02%-1.45K99.78%-246105.02%4.58K-97.60%1.16K-169.51%-136.15K-91.78%16.1K---109.44K
End cash Position -50.06%3.08M-51.50%3.84M-66.96%3.45M-66.96%3.45M-42.86%5.07M-40.81%6.16M-36.28%7.91M-29.83%10.43M-29.83%10.43M126.44%8.87M
Free cash from 57.12%-745.62K47.84%-1.31M26.41%-6.63M63.98%-1.31M-10.88%-1.08M8.49%-1.74M0.06%-2.5M-86.42%-9.01M-14.83%-3.63M-3,907.55%-972.22K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data